Adezmapimod
CAS: 152121-47-6
Ref. TM-T1764
5mg | 35.00 € | ||
10mg | 51.00 € | ||
50mg | 69.00 € | ||
100mg | 97.00 € | ||
200mg | 167.00 € | ||
500mg | 272.00 € | ||
1ml*10 (DMSO) | 54.00 € |
Product Information
- PB 203580, RWJ 64809, SB203580
- 4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine
- 4-{4-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl}pyridine
- Birb 203580
- Pb 203580
- Pyridine, 4-[4-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-5-yl]-
- Pyridine, 4-[5-(4-fluorophenyl)-2-[4-(methylsulfinyl)phenyl]-1H-imidazol-4-yl]-
- Rwj 64809
- Sb-203580
Adezmapimod (SB 203580) is a p38 MAPK inhibitor (IC50=0.3-0.5 μM) that is selective and ATP-competitive. Adezmapimod possesses autophagy and mitochondrial autophagy activating activity. Adezmapimod displays more than 100-fold higher selectivity than PKB, LCK, and GSK-3β.
Chemical properties
Technical inquiry about: TM-T1764 Adezmapimod
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.